Inhibitory Effect of Lidocaine on Colonic Spasms during Colonoscopy

Inhibitory Effect of Lidocaine on Colonic Spasms during Colonoscopy - Lidocaine Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012352

Enrollment

Registered

2013-11-25

Start date

2013-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal disease

Interventions

Lidocaine spray Peppermint spray

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have colonic lesions for meticulous observation

Exclusion criteria

Exclusion criteria: Lidocaine allergy Inflammatory bowel disease including ulcerative colitis, Crhon disease and etc.

Design outcomes

Primary

Measure	Time frame
lasting time of colonic spasm	—

Secondary

Measure	Time frame
number of colonic spasm, patient tolerance, occurrence of complication, occurrence of rebound phenomenon, impression of colonoscopist	—

Countries

Japan

Contacts

Public ContactKazutomo Togashi

Aizu Medical Center, Fukushima Medical University Department of Coloproctology

togashik@fmu.ac.jp0242-75-2100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026